abrdn Life Sciences Investors
HQL
66 hedge funds and large institutions have $97M invested in abrdn Life Sciences Investors in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 8 closing their positions.
123% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 13
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
18% more capital invested
Capital invested by funds: $82.2M → $97M (+$14.8M)
6% more funds holding
Funds holding: 62 → 66 (+4)
1% more ownership
Funds ownership: 19.87% → 20.87% (+1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$2.84M |
| 2 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$1.77M |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
+$1.33M |
| 4 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$809K |
| 5 |
TWM
Titus Wealth Management
Larskpur,
California
|
+$462K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$1.04M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$1.04M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$792K |
| 4 |
Cohen & Steers
New York
|
-$646K |
| 5 |
Morgan Stanley
New York
|
-$402K |
HQL Hedge Fund Activity: Q4 2020 in Review
66 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q4 2020, worth a combined $97M — up 18% from $82.2M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new HQL positions and 8 closed out — a net gain of 4 holders — while 29 added to existing stakes and 13 trimmed.
The largest buyer was Wells Fargo, adding an estimated $2.84M. The largest seller was Curi RMB Capital, exiting entirely with an estimated $1.04M sold.
- 66 institutional investors held abrdn Life Sciences Investors (HQL) as of Q4 2020, up from 62 in Q3 2020.
- Funds reported $97M of abrdn Life Sciences Investors stock for Q4 2020, up 18% quarter-over-quarter.
- 12 funds opened new abrdn Life Sciences Investors positions in Q4 2020 and 8 closed out, a net change of +4 holders.
- The largest abrdn Life Sciences Investors buyer in Q4 2020 was Wells Fargo, an estimated $2.84M added.
- The largest abrdn Life Sciences Investors seller in Q4 2020 was Curi RMB Capital, an estimated $1.04M sold.
Based on aggregated 13F filings for Q4 2020.